Search results
MacroGenics reports progress in prostate cancer study By Investing.com
Investing.com· 10 hours agoThe study investigates vobra duo, an antibody-drug conjugate (ADC), in patients with metastatic...
O.J. Simpson died from prostate cancer, not COVID-19 vaccine | Fact check
USA TODAY via Yahoo News· 7 days agoA television news outlet in Florida reported in February, about two months before Simpson's death, that he had been diagnosed with prostate cancer. A statement released by ...
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue...
Digital Journal· 14 hours agoTORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 2 days agoThe company's revenue reached $96.8 million, marking a 17% increase from the same period last year,...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
St. Louis Post-Dispatch· 7 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study evaluating adjuvant treatment with ERLEADA® (apalutamide) and androgen deprivation therapy (ADT ...
Earnings call: FibroGen reports Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 3 days agoThe company highlighted the upcoming top line data from Phase 3 studies for pamrevlumab in...
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga via Yahoo Finance· 4 days agoOn Sunday, Johnson & Johnson (NYSE:JNJ) ) released updated results from an open-label, multicenter,...
Dr. Roach: Brown semen usually doesn't present a health concern
St. Louis Post-Dispatch· 1 day agoDr. Roach: I am an 85-year-old male. Other than being a Type 2 diabetic, I am still active and in good health. I do have a concern; on the rare
Obesity, poor diet & physical inactivity driving early onset of cancers: Health expert
Investing.com· 6 days agoNew Delhi, May 4 (IANS) Obesity, poor diet, and physical inactivity are driving the onset of several...
Citi cuts ORIC Pharmaceuticals stock price target post 1Q24 pipeline update By Investing.com
Investing.com· 3 days agoORIC Pharmaceuticals is set to begin combination trials for its drug candidate, ORIC-944, a PRC2...